Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia
of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was …

Idiopathic pulmonary fibrosis (IPF) is a form of idiopathic interstitial pneumonia that currently
carries a poor prognosis and remains incurable, though antifibrotic therapy can slow …

Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of
unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age …

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. Despite multiple recent clinical trials, there is no strong evidence supporting a …

Idiopathic pulmonary fibrosis (IPF), with the histologic correlate of usual interstitial
pneumonia, has an almost uniformly poor prognosis when compared with other idiopathic …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia
of unknown cause that is limited to the lungs [1]. The disease is inevitably fatal, with an …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown etiology
characterized by fibrosis of the interstitium, resulting in progressive respiratory insufficiency …

Idiopathic pulmonary fibrosis (IPF), the most common form of fibrosing idiopathic interstitial
pneumonia, is an inexorably progressive disease with a 5-year survival of~ 20%. In the last …

Idiopathic pulmonary fibrosis (IPF) is the most prevalent of the idiopathic interstitial
pneumonias and its incidence seems to be increasing [1–4]. IPF is generally considered to …

Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by
progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be …